{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:40:03Z","timestamp":1794382803394,"version":"4.9.0"},"publisher-location":"New York, NY","reference-count":65,"publisher":"Springer New York","isbn-type":[{"value":"9781441971845","type":"print"},{"value":"9781441971852","type":"electronic"}],"license":[{"start":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T00:00:00Z","timestamp":1283472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T00:00:00Z","timestamp":1283472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-1-4419-7185-2_17","type":"book-chapter","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T13:33:54Z","timestamp":1291124034000},"page":"243-260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Antiviral Therapy of CMV Disease in Children"],"prefix":"10.1007","author":[{"given":"Mike","family":"Sharland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Luck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,3]]},"reference":[{"issue":"5","key":"17_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/rmv.544","volume":"17","author":"SC Dollard","year":"2007","unstructured":"Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355\u201363.","journal-title":"Rev Med Virol"},{"key":"17_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/rmv.535","volume":"17","author":"A Kenneson","year":"2007","unstructured":"Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253\u201376.","journal-title":"Rev Med Virol"},{"key":"17_CR3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1471-0528.1991.tb13358.x","volume":"98","author":"PD Griffiths","year":"1991","unstructured":"Griffiths PD, Baboonian C, Rutter D, Peckham C. Congenital and maternal cytomegalovirus infections in a London population. Br J Obstet Gynaecol. 1991;98:135\u201340.","journal-title":"Br J Obstet Gynaecol"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00006454-200301000-00012","volume":"22","author":"M Barbi","year":"2003","unstructured":"Barbi M, Binda S, Caroppo S, Ambrosetti U, Corbetta C, Sergi P. A wider role for congenital cytomegalovirus infection in sensorineural hearing loss. Pediatr Infect Dis J. 2003;22:39\u201342.","journal-title":"Pediatr Infect Dis J"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jcv.2005.09.017","volume":"35","author":"WE Nance","year":"2006","unstructured":"Nance WE, Lim BG, Dodson KM. Importance of congenital cytomegalovirus infections as a cause for pre-lingual hearing loss. J Clin Virol. 2006;35:221\u20135.","journal-title":"J Clin Virol"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1542\/peds.110.4.762","volume":"110","author":"LB Rivera","year":"2002","unstructured":"Rivera LB, Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection. Pediatrics. 2002;110:762\u20137.","journal-title":"Pediatrics"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1067\/mpd.2001.112061","volume":"138","author":"DE Noyola","year":"2001","unstructured":"Noyola DE, Demmler GJ, Nelson CT, Griesser C, Williamson WD, Atkins JT, Rozelle J, Turcich M, Llorente AM, Sellers-Vinson S, Reynolds A, Bale JF Jr, Gerson P, Yow MD. Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr. 2001;138:325\u201331.","journal-title":"J Pediatr"},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/S0140-6736(00)02350-3","volume":"355","author":"VC Emery","year":"2000","unstructured":"Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet. 2000;355:2032\u20136.","journal-title":"Lancet"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/(SICI)1096-9071(199706)52:2<200::AID-JMV14>3.0.CO;2-O","volume":"52","author":"AV Cope","year":"1997","unstructured":"Cope AV, Sweny P, Sabin C, Rees L, Griffiths PD, Emery VC. Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation. J Med Virol. 1997;52:200\u20135.","journal-title":"J Med Virol"},{"key":"17_CR10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/infdis\/132.5.568","volume":"132","author":"S Stagno","year":"1975","unstructured":"Stagno S, Reynolds DW, Tsiantos A, Fuccillo DA, Long W, Alford CA. Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections. J Infect Dis 1975;132:568\u201377.","journal-title":"J Infect Dis"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1086\/426456","volume":"191","author":"RD Bradford","year":"2005","unstructured":"Bradford RD, Cloud G, Lakeman AD, Boppana S, Kimberlin DW, Jacobs R, Demmler G, Sanchez P, Britt W, Soong SJ, Whitley RJ. Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system. J Infect Dis. 2005;191:227\u201333.","journal-title":"J Infect Dis"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jpeds.2005.01.059","volume":"146","author":"SB Boppana","year":"2005","unstructured":"Boppana SB, Fowler KB, Pass RF, Rivera LB, Bradford RD, Lakeman FD, Britt WJ. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr. 2005;146:817\u201323.","journal-title":"J Pediatr"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1542\/peds.2005-0629","volume":"117","author":"M Lanari","year":"2006","unstructured":"Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B, Landini MP, Faldella G. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics. 2006;117:e76\u201383.","journal-title":"Pediatrics"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"F280","DOI":"10.1136\/adc.2007.119230","volume":"93","author":"S Walter","year":"2008","unstructured":"Walter S, Atkinson C, Sharland M, Rice P, Raglan E, Emery VC, Griffiths PD. Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss. Arch Dis Child Fetal Neonatal Ed. 2008;93:F280\u20135.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/INF.0b013e3181979a27","volume":"28","author":"SA Ross","year":"2009","unstructured":"Ross SA, Novak Z, Fowler KB, Arora N, Britt WJ, Boppana SB. Cytomegalovirus blood viral load and hearing loss in young children with congenital infection. Pediatr Infect Dis J. 2009;28:588\u201392.","journal-title":"Pediatr Infect Dis J."},{"issue":"3","key":"17_CR16","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/S1386-6532(02)00188-9","volume":"25","author":"G Halwachs-Baumann","year":"2002","unstructured":"Halwachs-Baumann G, Genser B, Pailer S, Engele H, Rosegger H, Schalk A, Kessler H, Truschnig-Wilders. M. Human cytomegalovirus load in various body fluids of congenitally infected newborns. J Clin Virol. 2002;25(Suppl 3):S81\u2013S87.","journal-title":"J Clin Virol."},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/adc.71.5.414","volume":"71","author":"J Kohyama","year":"1994","unstructured":"Kohyama J, Kajiwara M, Shimohira M, Iwakawa Y, Okawa H. Human cytomegalovirus DNA in cerebrospinal fluid. Arch Dis Child. 1994;71:414\u201318.","journal-title":"Arch Dis Child"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1056\/NEJM198005083021908","volume":"302","author":"S Stagno","year":"1980","unstructured":"Stagno S, Reynolds DW, Pass RF, Alford CA. Breast milk and the risk of cytomegalovirus infection. N Engl J Med. 1980;302:1073\u20136.","journal-title":"N Engl J Med"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00006454-199801000-00012","volume":"17","author":"M Vochem","year":"1998","unstructured":"Vochem M, Hamprecht K, Jahn G, Speer CP. Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J. 1998;17:53\u20138.","journal-title":"Pediatr Infect Dis J."},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0140-6736(00)04043-5","volume":"357","author":"K Hamprecht","year":"2001","unstructured":"Hamprecht K, Maschmann J, Vochem M, Dietz K, Speer CP, Jahn G. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet. 2001;357:513\u201318.","journal-title":"Lancet"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jcv.2007.12.005","volume":"41","author":"K Hamprecht","year":"2008","unstructured":"Hamprecht K, Maschmann J, Jahn G, Poets CF, Goelz R. Cytomegalovirus transmission to preterm infants during lactation. J Clin Virol. 2008;41:198\u2013205.","journal-title":"J Clin Virol"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0022-3476(84)80941-5","volume":"104","author":"ML Kumar","year":"1984","unstructured":"Kumar ML, Nankervis GA, Cooper AR, Gold E. Postnatally acquired cytomegalovirus infections in infants of CMV-excreting mothers. J Pediatr. 1984;104:669\u201373.","journal-title":"J Pediatr"},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"F367","DOI":"10.1136\/adc.2003.032821","volume":"89","author":"JL Cheong","year":"2004","unstructured":"Cheong JL, Cowan FM, Modi N. Gastrointestinal manifestations of postnatal cytomegalovirus infection in infants admitted to a neonatal intensive care unit over a five year period. Arch Dis Child Fetal Neonatal Ed. 2004;89:F367\u20139.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0022-3476(85)80533-3","volume":"107","author":"SG Paryani","year":"1985","unstructured":"Paryani SG, Yeager AS, Hosford-Dunn H, Johnson SJ, Malachowski N, Ariagno RL, Stevenson DK. Sequelae of acquired cytomegalovirus infection in premature and sick term infants. J Pediatr. 1985;107:451\u20136.","journal-title":"J Pediatr."},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/00006454-200404000-00009","volume":"23","author":"B Vollmer","year":"2004","unstructured":"Vollmer B, Seibold-Weiger K, Schmitz-Salue C, Hamprecht K, Goelz R, Krageloh-Mann I, Speer CP. Postnatally acquired cytomegalovirus infection via breast milk: effects on hearing and development in preterm infants. Pediatr Infect Dis J. 2004;23:322\u20137.","journal-title":"Pediatr Infect Dis J."},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1086\/340653","volume":"185","author":"VC Emery","year":"2002","unstructured":"Emery VC, Hassan-Walker AF, Burroughs AK, Griffiths PD. Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. J Infect Dis 2002;185:1723\u20138.","journal-title":"J Infect Dis"},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1086\/514145","volume":"176","author":"AV Cope","year":"1997","unstructured":"Cope AV, Sabin C, Burroughs A, Rolles K, Griffiths PD, Emery VC. Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. J Infect Dis 1997;176:1484\u201390.","journal-title":"J Infect Dis"},{"key":"17_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/sj.bmt.1701139","volume":"21","author":"D Gor","year":"1998","unstructured":"Gor D, Sabin C, Prentice HG, Vyas N, Man S, Griffiths PD, Emery VC. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor\/recipient serostatus, acute GVHD and CMV disease. Bone Marrow Transplant. 1998;21:597\u2013605.","journal-title":"Bone Marrow Transplant"},{"key":"17_CR29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/02724936.1996.11747852","volume":"16","author":"PM Jeena","year":"1996","unstructured":"Jeena PM, Coovadia HM, Chrystal V. Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants. Ann Trop Paediatr. 1996;16:361\u20138.","journal-title":"Ann Trop Paediatr"},{"key":"17_CR30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/tropej\/fmm036","volume":"53","author":"H Rabie","year":"2007","unstructured":"Rabie H, de Boer A, van den Bos S, Cotton MF, Kling S, Goussard P. Children with human immunodeficiency virus infection admitted to a paediatric intensive care unit in South Africa. J Trop Pediatr. 2007;53:270\u20133.","journal-title":"J Trop Pediatr"},{"key":"17_CR31","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/S0140-6736(07)60670-9","volume":"369","author":"LM McNally","year":"2007","unstructured":"McNally LM, Jeena PM, Gajee K, Thula SA, Sturm AW, Cassol S, Tomkins AM, Coovadia HM, Goldblatt D. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet. 2007;369:1440\u201351.","journal-title":"Lancet"},{"key":"17_CR32","unstructured":"O\u2019Connell N, Rabie H, Freeman N, Cotton M Cytomegalovirus retinitis in HIV-1 infected South African children. 2009. In 5th International AIDS Society Conference on pathogenesis and treatment, Cape Town, South Africa."},{"key":"17_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/clpt.1993.4","volume":"53","author":"JM Trang","year":"1993","unstructured":"Trang JM, Kidd L, Gruber W, Storch G, Demmler G, Jacobs R, Dankner W, Starr S, Pass R, Stagno S et al. Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Clin Pharmacol Ther. 1993;53:15\u201321.","journal-title":"Clin Pharmacol Ther"},{"key":"17_CR34","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1128\/AAC.40.9.2202","volume":"40","author":"XJ Zhou","year":"1996","unstructured":"Zhou XJ, Gruber W, Demmler G, Jacobs R, Reuman P, Adler S, Shelton M, Pass R, Britt B, Trang JM, Whitley RJ, Sommadossi JP. Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Antimicrob Agents Chemother. 1996;40:2202\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"17_CR35","doi-asserted-by":"crossref","unstructured":"Pacifici GM. Pharmacokinetics of antivirals in neonate. Early Hum Dev. 2005 Sep;81(9):773\u201380.","DOI":"10.1016\/j.earlhumdev.2005.06.001"},{"issue":"6","key":"17_CR36","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1586\/14787210.4.6.1005","volume":"4","author":"S Luck","year":"2006","unstructured":"Luck S, Sharland M, Griffiths P, Jenkins S. Advances in the antiviral therapy of herpes virus infection in children. Amend Expert Rev Anti Infect Ther. 2006;4(6):1005\u201320.","journal-title":"Amend Expert Rev Anti Infect Ther"},{"key":"17_CR37","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1086\/528376","volume":"197","author":"DW Kimberlin","year":"2008","unstructured":"Kimberlin DW, Acosta EP, Sanchez PJ, Sood S, Agrawal V, Homans J, Jacobs RF, Lang D, Romero JR, Griffin J, Cloud GA, Lakeman FD, Whitley RJ. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis 2008;197:836\u201345.","journal-title":"J Infect Dis"},{"key":"17_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/BF00866315","volume":"6","author":"E Jacqz-Aigrain","year":"1992","unstructured":"Jacqz-Aigrain E, Macher MA, Sauvageon-Marthe H, Brun P, Loirat C. Pharmacokinetics of ganciclovir in renal transplant children. Pediatr Nephrol. 1992;6:194\u20136.","journal-title":"Pediatr Nephrol"},{"key":"17_CR39","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00467-003-1226-x","volume":"18","author":"D Zhang","year":"2003","unstructured":"Zhang D, Lapeyraque AL, Popon M, Loirat C, Jacqz-Aigrain E. Pharmacokinetics of ganciclovir in pediatric renal transplant recipients. Pediatr Nephrol. 2003;18:943\u20138.","journal-title":"Pediatr Nephrol."},{"key":"17_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1399-3046.2006.00669.x","volume":"11","author":"J Vethamuthu","year":"2007","unstructured":"Vethamuthu J, Feber J, Chretien A, Lampe D, Filler G. Unexpectedly high inter- and intrapatient variability of ganciclovir levels in children. Pediatr Transplant. 2007;11:301\u20135.","journal-title":"Pediatr Transplant"},{"key":"17_CR41","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7","volume":"89","author":"M Sugawara","year":"2000","unstructured":"Sugawara M, Huang W, Fei YJ, Leibach FH, Ganapathy V, Ganapathy ME. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. J Pharm Sci. 2000;89:781\u20139.","journal-title":"J Pharm Sci"},{"key":"17_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1586\/14787210.2.1.27","volume":"2","author":"RR Razonable","year":"2004","unstructured":"Razonable RR, Paya CV. Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts. Expert Rev Anti Infect Ther. 2004;2:27\u201341.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"17_CR43","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/sj.clpt.6100150","volume":"81","author":"EP Acosta","year":"2007","unstructured":"Acosta EP, Brundage RC, King JR, Sanchez PJ, Sood S, Agrawal V, Homans J, Jacobs RF, Lang D, Romero JR, Griffin J, Cloud G, Whitley R, Kimberlin DW. Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther. 2007;81:867\u201372.","journal-title":"Clin Pharmacol Ther"},{"key":"17_CR44","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1515\/JPM.2005.065","volume":"33","author":"CF Meine Jansen","year":"2005","unstructured":"Meine Jansen CF, Toet MC, Rademaker CM, Ververs TF, Gerards LJ, van Loon AM. Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir. J Perinat Med. 2005;33:364\u20136.","journal-title":"J Perinat Med"},{"key":"17_CR45","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2165\/00003088-200948050-00004","volume":"48","author":"W Zhao","year":"2009","unstructured":"Zhao W, Baudouin V, Zhang D, Deschenes G, Guellec CL, Jacqz-Aigrain. E. Population pharmacokinetics of ganciclovir following administration of valganciclovir in paediatric renal transplant patients. Clin Pharmacokinet. 2009;48:321\u20138.","journal-title":"Clin Pharmacokinet"},{"key":"17_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/rmv.454","volume":"15","author":"N Strazielle","year":"2005","unstructured":"Strazielle N, Ghersi-Egea JF. Factors affecting delivery of antiviral drugs to the brain. Rev Med Virol. 2005;15:105\u201333.","journal-title":"Rev Med Virol."},{"key":"17_CR47","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/clpt.1986.177","volume":"40","author":"C Fletcher","year":"1986","unstructured":"Fletcher C, Sawchuk R, Chinnock B, de Miranda P, Balfour HH Jr. Human pharmacokinetics of the antiviral drug DHPG. Clin Pharmacol Ther. 1986;40:281\u20136.","journal-title":"Clin Pharmacol Ther"},{"key":"17_CR48","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1128\/AAC.47.8.2438-2441.2003","volume":"47","author":"J Lycke","year":"2003","unstructured":"Lycke J, Malmestrom C, Stahle L. Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir. Antimicrob Agents Chemother. 2003;47:2438\u201341.","journal-title":"Antimicrob Agents Chemother."},{"issue":"2","key":"17_CR49","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0022-3476(94)70327-2","volume":"124","author":"G Nigro","year":"1994","unstructured":"Nigro G, Scholz H, Bartmann U. Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience. J Pediatr 1994;124(2):318\u201322.","journal-title":"J Pediatr"},{"key":"17_CR50","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1086\/516445","volume":"175","author":"RJ Whitley","year":"1997","unstructured":"Whitley RJ, Cloud G, Gruber W, Storch GA, Demmler GJ, Jacobs RF, Dankner W, Spector SA, Starr S, Pass RF, Stagno S, Britt WJ, Alford C Jr, Soong S, Zhou XJ, Sherrill L, FitzGerald JM, Sommadossi JP. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1997;175:1080\u20136.","journal-title":"J Infect Dis"},{"key":"17_CR51","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/infdis\/171.6.1603","volume":"171","author":"P Cinque","year":"1995","unstructured":"Cinque P, Baldanti F, Vago L, Terreni MR, Lillo F, Furione M, Castagna A, Monforte AD, Lazzarin A, Linde A. Ganciclovir therapy for cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid. J Infect Dis 1995;171:1603\u20136.","journal-title":"J Infect Dis"},{"key":"17_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1084\/jem.190.2.177","volume":"190","author":"VC Emery","year":"1999","unstructured":"Emery VC, Cope AV, Bowen EF, Gor D, Griffiths PD. The dynamics of human cytomegalovirus replication in vivo. J Exp Med. 1999;190:177\u201382.","journal-title":"J Exp Med"},{"key":"17_CR53","doi-asserted-by":"publisher","first-page":"8039","DOI":"10.1073\/pnas.140123497","volume":"97","author":"VC Emery","year":"2000","unstructured":"Emery VC, Griffiths PD. Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy. Proc Natl Acad Sci USA. 2000;97:8039\u201344.","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR54","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/135965350901400512","volume":"14","author":"G Boivin","year":"2009","unstructured":"Boivin G, Goyette N, Rollag H, Jardine AG, Pescovitz MD, Asberg A, Ives J, Hartmann A, Humar A. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Antivir Ther. 2009;14:697\u2013704.","journal-title":"Antivir Ther"},{"key":"17_CR55","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0140-6736(00)02607-6","volume":"356","author":"AP Limaye","year":"2000","unstructured":"Limaye AP, Corey L, Koelle DM, Davis CL, Boeckh M. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 2000;356:645\u20139.","journal-title":"Lancet"},{"key":"17_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","volume":"143","author":"DW Kimberlin","year":"2003","unstructured":"Kimberlin DW, Lin CY, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Kiell JM, Soong SJ, Whitley RJ. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143:16\u201325.","journal-title":"J Pediatr."},{"key":"17_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0027-5107(02)00105-7","volume":"505","author":"MT Tomicic","year":"2002","unstructured":"Tomicic MT, Bey E, Wutzler P, Thust R, Kaina B. Comparative analysis of DNA breakage, chromosomal aberrations and apoptosis induced by the anti-herpes purine nucleoside analogues aciclovir, ganciclovir and penciclovir. Mutat Res. 2002;505:1\u201311.","journal-title":"Mutat Res"},{"key":"17_CR58","first-page":"504","volume":"22","author":"MG Michaels","year":"2003","unstructured":"Michaels MG, Greenberg DP, Sabo DL, Wald ER. Treatment of children with congenital cytomegalovirus infection with ganciclovir. Pediatr Infect Dis J 2003;22:504\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"17_CR59","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.inf.0000107025.29429.c6","volume":"23","author":"P Rojo","year":"2004","unstructured":"Rojo P and Ramos JT. Ganciclovir treatment of children with congenital cytomegalovirus infection. Pediatr Infect Dis J 2004;23:80\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"17_CR60","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/01.inf.0000177280.28694.00","volume":"24","author":"N Tanaka-Kitajima","year":"2005","unstructured":"Tanaka-Kitajima N, Sugaya N, Futatani T, Kanegane H, Suzuki C, Oshiro M, Hayakawa M, Futamura M, Morishima T and Kimura H. Ganciclovir therapy for congenital cytomegalovirus infection in six infants. Pediatr Infect Dis J 2005;24:782\u20135.","journal-title":"Pediatr Infect Dis J"},{"key":"17_CR61","doi-asserted-by":"crossref","unstructured":"Oliver S, Cloud G, S\u00e1nchez P, Demmler G, Dankner W, Shelton M, Jacobs R, Vaudry W, Pass R, Soong S, Whitley R, Kimberlin D. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009 Dec;46(Suppl 4):S22\u2013S26.","DOI":"10.1016\/j.jcv.2009.08.012"},{"key":"17_CR62","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/sj.jp.7211854","volume":"28","author":"A Muller","year":"2008","unstructured":"Muller A, Eis-Hubinger AM, Brandhorst G, Heep A, Bartmann P, Franz AR. Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. J Perinatol. 2008;28:74\u20136.","journal-title":"J Perinatol"},{"key":"17_CR63","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000103982","volume":"92","author":"R Takahashi","year":"2007","unstructured":"Takahashi R, Tagawa M, Sanjo M, Chiba H, Ito T, Yamada M, Nakae S, Suzuki A, Nishimura H, Naganuma M, Tominaga N, Moriuchi M, Moriuchi H. Severe postnatal cytomegalovirus infection in a very premature infant. Neonatology. 2007;92:236\u20139.","journal-title":"Neonatology"},{"key":"17_CR64","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/00005176-200202000-00009","volume":"34","author":"B Fischler","year":"2002","unstructured":"Fischler B, Casswall TH. Malmborg P and Nemeth A. Ganciclovir treatment in infants with cytomegalovirus infection and cholestasis. J Pediatr Gastroenterol Nutr. 2002;34:154\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"17_CR65","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s007050050103","volume":"142","author":"G Nigro","year":"1997","unstructured":"Nigro G, Krzysztofiak A, Bartmann U, Clerico A, Properzi E, Valia S, Castello M. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children. Arch Virol. 1997;142:573\u201380.","journal-title":"Arch Virol"}],"container-title":["Advances in Experimental Medicine and Biology","Hot Topics in Infection and Immunity in Children VII"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-7185-2_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T23:49:21Z","timestamp":1676677761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4419-7185-2_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,3]]},"ISBN":["9781441971845","9781441971852"],"references-count":65,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-7185-2_17","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4419-7185-2","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,3]]},"assertion":[{"value":"3 September 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}